table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID-19 severe or critically
COVID-19 prophylaxis (excluding children)
Inactivated virus vaccine Li
CoronaVac (SinoVac) Faria Chile study ... Zhang Bonfa PROFISCOV ... Wan Wu Sinovac Turkish Trial DOUBLON SinoVac-PROFISCOV phase 3 Hitchings
Covaxin, Bharat Biotech (BBV152) Ella
Sinopharm Beijing (BBIBP-CorV) Rearte Xia ... Sultan Kanokudom Ashmawy
Sinopharm Wuhan Xia ... Sinopharm Wuhan Vero cell

2 studies excluded by filtering options 2

9178 Liu, 2021 210excludedrisk of bias not avaialble
9240 Chen, 2021 210excludedrisk of bias not avaialble

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons